Avenue Therapeutics, Inc. (ATXI)

NASDAQ: ATXI · IEX Real-Time Price · USD

0.135

-0.001 (-0.37%)

At close: Apr 18, 2024, 3:43 PM

0.130

-0.004 (-3.19%)

After-hours: Apr 18, 2024, 7:23 PM EDT

Avenue Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015
Market Capitalization	6	2	6	17	100	160	58	37	-	-
Market Cap Growth	-	-61.48%	-67.39%	-82.96%	-37.70%	177.80%	54.94%	-	-	-
Enterprise Value	4	0	-1	13	97	151	55	15	6	4
PE Ratio	-0.21	-0.21	-1.56	-4.55	-19.35	-6.17	-2.67	-3.03	-	-
PB Ratio	3.77	1.35	1.42	4.92	42.24	23.52	-91.25	1.92	-	-
P/FCF Ratio	-0.23	-0.23	-0.73	-4.53	-17.75	-6.09	-3.16	-5.46	-	-
P/OCF Ratio	-0.23	-0.23	-0.73	-4.53	-21.60	-6.09	-3.16	-5.46	-	-
EV/EBITDA Ratio	-0.03	-0.03	0.33	-3.54	-18.74	-5.84	-2.55	-1.29	-2.21	-0.80
EV/EBIT Ratio	-0.03	-0.03	0.33	-3.54	-18.74	-5.84	-2.55	-1.29	-2.21	-0.80
EV/FCF Ratio	-0.04	-0.04	0.15	-3.52	-17.20	-5.76	-3.01	-2.26	-3.48	-4.31
Debt / Equity Ratio	-	-	-	-	-	-	-	-	-0.71	-0.75
Debt / EBITDA Ratio	-	-	-	-	-	-	-	-	-2.29	-0.80
Debt / FCF Ratio	-	-	-	-	-	-	-	-	-3.60	-4.32
Quick Ratio	1.49	1.49	1.87	7.57	3.53	4.13	0.52	7.81	0.03	0.01
Current Ratio	1.55	1.55	1.91	7.78	3.66	4.22	0.88	7.95	0.03	0.01
Interest Coverage	-	-	-	-	-	-	-	-31.69	-4.19	-12.64
Return on Equity (ROE)	468.70%	468.70%	-252.70%	-276.00%	-133.20%	-195.50%	-521.30%	-79.30%	47.50%	-
Return on Assets (ROA)	-333.00%	-333.00%	-136.90%	-191.80%	-105.00%	-151.90%	-249.90%	-58.90%	-3011.40%	-
Return on Capital (ROIC)	-919.09%	-919.09%	-205.97%	-108.32%	-220.98%	-386.25%	3457.37%	-58.93%	100.13%	382.24%
Earnings Yield	-174.18%	-486.53%	-64.15%	-21.97%	-5.17%	-16.20%	-37.42%	-32.99%	-	-
FCF Yield	-158.64%	-443.11%	-137.19%	-22.08%	-5.63%	-16.42%	-31.64%	-18.30%	-	-
Buyback Yield / Dilution	-384.71%	-384.71%	-92.84%	-2.97%	-4.99%	-53.54%	-54.32%	-131.95%	-5.85%	-
Total Shareholder Return	-384.71%	-384.71%	-92.84%	-2.97%	-4.99%	-53.54%	-54.32%	-131.95%	-5.85%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).